Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy
Purpose
Patients with pancreatic cancer receiving neoadjuvant chemotherapy often experience functional decline, treatment interruptions, and clinical deterioration, and these risks may be amplified when frailty is present.
Conditions
- Physiological Reactivity to Cues
- Physical Exercise
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Age ≥18 years 2. Diagnosis of pancreatic cancer that is potentially resectable per the treating clinical team's assessment. 3. Planned to receive or actively receiving neoadjuvant chemotherapy prior to surgery. 4. Frail or pre-frail as defined by the protocol-specified frailty assessment tool (e.g., Fried Frailty Phenotype; pre-frail = 1-2 criteria; frail => 3 criteria). 5. Able to provide written informed consent. 6. Medically appropriate to participate in supervised, symptom-limited exercise as determined by study screening and, if indicated, the treating clinician's input. 7. Able to complete study assessments and questionnaires in English or Spanish (using IRB- approved instruments/materials).
Exclusion Criteria
- Adults unable to consent. 2. Medical condition that, in the judgment of the investigator and/or treating clinician, makes exercise unsafe (e.g., unstable angina, uncontrolled arrhythmia, decompensated heart failure, uncontrolled severe pulmonary disease). 3. Any absolute contraindication to exercise participation/testing per institutional standards. 4. Severe symptoms or functional impairment that prevents safe participation despite program modification. 5. Inability to comply with the intervention schedule and study procedures despite reasonable scheduling accommodations.
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- N/A
- Intervention Model
- Single Group Assignment
- Intervention Model Description
- Study focus on the feasibility and safety of delivering a 36-session targeted physical exercise program to frail adults with pancreatic cancer receiving neoadjuvant chemotherapy.
- Primary Purpose
- Supportive Care
- Masking
- None (Open Label)
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
|
Other physical exercise to frail adults w pancreatic ca who are receiving neoadjuvant chemotherapy |
Eligible participants may be enrolled if they plan to initiate or are actively receiving neoadjuvant chemotherapy, provided they meet all inclusion criteria and have no contraindications to supervised exercise |
|
Recruiting Locations
Chicago, Illinois 60612
More Details
- Status
- Recruiting
- Sponsor
- University of Illinois at Chicago
Detailed Description
Patients with pancreatic cancer receiving neoadjuvant chemotherapy often experience functional decline, treatment interruptions, and clinical deterioration, and these risks may be amplified when frailty is present. Frailty is increasingly recognized as an important predictor of worse treatment tolerance and perioperative outcomes in pancreatic cancer populations, including higher postoperative complication risk. The proposed targeted physical therapy program is a supervised, individualized physical activity program designed to improve strength and functional performance using low-intensity, resistance-based exercise training. In this proposal, the study will evaluate the effects of the targeted physical exercise program in frail pancreatic cancer patients receiving neoadjuvant chemotherapy by generating key data on feasibility and safety and by providing preliminary estimates of change in functional outcomes to inform the design of a future, adequately powered study.